Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease
Launched by GAZI UNIVERSITY · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how exercise capacity, muscle oxygen levels, and physical activity differ between patients with interstitial lung disease (ILD) and healthy individuals. ILD is a group of chronic lung conditions that can make it hard to breathe and impact overall health. The researchers want to understand how these factors, along with respiratory function and quality of life, compare in people with ILD versus those who are healthy. This is important because it could help improve care and support for patients with lung diseases.
To participate, patients with ILD need to be between 18 and 75 years old and diagnosed according to specific guidelines. They should not have had a recent lung infection or be dealing with certain serious health conditions. Healthy participants should be between 45 and 80 years old, with no chronic diseases. Everyone involved will undergo tests to evaluate their exercise capacity and other health measures. This study is currently recruiting participants, and it aims to provide valuable insights into how ILD affects physical abilities and overall well-being.
Gender
ALL
Eligibility criteria
- • Patients who will participate in the study;
- Inclusion Criteria:
- • Patients diagnosed with ILD according to ATS/ERS criteria,
- • Ages between 18 and 75,
- • Pulmonary infection during the previous month,
- • Participants who voluntarily participated in the study were included.
- Exclusion Criteria:
- * Patients were excluded if they had:
- • Acute pulmonary exacerbation or respiratory infection in the last four weeks
- • Obstructive lung disease
- • Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions
- • Recent participation in a planned exercise program (within three months)
- • Cognitive impairment affecting exercise test understanding
- • Contraindications to exercise testing per the American Sports Medicine Association
- • Cancer, renal, or hepatic disease
- • Aortic stenosis, complex arrhythmia, or aortic aneurysm
- • Serious cardiovascular diseases like uncontrolled hypertension, diabetes, heart failure, or arrhythmia
- • For healthy individuals who will participate in the study;
- Inclusion Criteria:
- • No diagnosed chronic disease,
- • Healthy adults between the ages of 45-80
- Exclusion Criteria:
- • Individuals with a Mini Mental State Assessment Scale score of less than 24,
- • A smoking history of at least 10 packs×years or more,
- • Having had COVID-19,
- • A BMI of \>30 kg/m2
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Study Director
Gazi University
Nazire Nur YILDIZ, M.Sc.
Principal Investigator
Nigde Omer Halisdemir University
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Principal Investigator
Gazi University
Beyzanur ÖYMEZ
Principal Investigator
Gazi University
Ayşenur GÜVENİR, M.Sc.
Principal Investigator
Yozgat Bozok University
Nilgün YILMAZ DEMİRCİ, Prof. Dr.
Principal Investigator
Gazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported